[1] Li D P,Li W,Feng J,et al.Adjuvant chemotherapy with sequential cytokine-induced killer(CIK) cells in stage IB non-small cell lung cancer. Oncol Res,2015,22(2):67-74.
[2] Marshall A,Lukk M,Kutter C,et al.Global gene expression profiling reveals SPINK1 as a potential hepatocellular carcinoma marker.PloS One,2013,8(3):e59459.
[3] Cong WM,Wu MC.New insights into molecular diagnostic patho-logy of primary liver cancer:Advances and challenges. Cancer Lett,2015,368(1):14-19.
[4] Huang O,Lu X,Xu X,et al.Fibrin-sealant-delivered cisplatin chemotherapy versus cisplatin hyperthermic intraperitoneal perfusion chemotherapy for locally advanced gastric cancer without peritoneal metastases:a randomized phase-II clinical trial with a 40-month follow-up. Cell Biochem Biophys,2015,71(2):1171-1180.
[5] Ba MC,Long H, Zhang XL,et al.Laparoscopic hyperthermic Intraperitoneal perfusion chemotherapy for patients with malignant ascites secondary to unresectable gastric cancer. J Laparoendosc Adv Surg Tech A,2016,26(1):32-39.
[6] Zhang T,Pan Q,Xiao S,et al.Docetaxel combined with intraperitoneal hyperthermic perfusion chemotherapy and hyperthermia in the treatment of advanced ovarian cancer. Oncol Lett,2016,11(5):3287-3292.
[7] Wang X,Hu Y,Ren M,et al.Efficacy and safety of radiofrequency ablation combined with transcatheter arterial chemoembolization for hepatocellular carcinomas compared with radiofrequency ablation alone:A time-to-event meta-analysis. Kor J Radiol,2016,17(1):93-102.
[8] Ida S,Ozaki N,Araki K,et al.SPINK1 status in colorectal cancer,impact on proliferation,and role in colitis-associated cancer. Mol Cancer Res,2015,13(7):1130-1130. |
